Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pyrotinib Treatment”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Testing effectiveness (Phase 2)UnknownNCT04963595
What this trial is testing

Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Zhiyong Yu 100
Testing effectiveness (Phase 2)UnknownNCT04988165
What this trial is testing

Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese Medicine

Who this might be right for
Diarrhea Caused by Antitumor Drugs
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableUnknownNCT05411276
What this trial is testing

A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2

Who this might be right for
HER2 Mutant Non-small Cell Lung Cancer
Beijing Chest Hospital 15
Testing effectiveness (Phase 2)UnknownNCT05042791
What this trial is testing

Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

Who this might be right for
HER2-positive Metastatic Breast Cancer
Jiangxi Provincial Cancer Hospital 362
Large-scale testing (Phase 3)Study completedNCT04447118
What this trial is testing

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Who this might be right for
Non-squamous NSCLCHER2 Exon 20 Mutation
Jiangsu HengRui Medicine Co., Ltd. 151
Large-scale testing (Phase 3)Looking for participantsNCT06958627
What this trial is testing

The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study

Who this might be right for
HER2 Positive Breast CancerPyrotinib Treatment
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 964
Not applicableLooking for participantsNCT06234137
What this trial is testing

A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer

Who this might be right for
Breast Neoplasm Female
Wang Ouchen 154
Large-scale testing (Phase 3)Looking for participantsNCT06278870
What this trial is testing

Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial

Who this might be right for
HER2-positive Metastatic Breast CancerFirst-line Treatment
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 312
Testing effectiveness (Phase 2)UnknownNCT05429294
What this trial is testing

Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038

Who this might be right for
HER2-positive Breast Cancer
First Affiliated Hospital Xi'an Jiaotong University 209
Not applicableUnknownNCT05764941
What this trial is testing

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
The First Affiliated Hospital with Nanjing Medical University 100
Not applicableUnknownNCT05560308
What this trial is testing

Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

Who this might be right for
HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
Tianjin Medical University Cancer Institute and Hospital 50
Post-approval studies (Phase 4)Looking for participantsNCT07600164
What this trial is testing

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Who this might be right for
HER2 + Breast CancerAdvanced Breast Cancer
Peking University People's Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT05638594
What this trial is testing

Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 236
Testing effectiveness (Phase 2)Looking for participantsNCT07335081
What this trial is testing

CtDNA in HER2+ EBC Neoadjuvant Treatment

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 60
Not applicableLooking for participantsNCT06035016
What this trial is testing

Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer

Who this might be right for
HER2-positive Breast CancerEarly-stage Breast Cancer
Peking Union Medical College Hospital 300
Not applicableUnknownNCT05561686
What this trial is testing

Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Hunan Cancer Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06483386
What this trial is testing

Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 109
Large-scale testing (Phase 3)Not Yet RecruitingNCT04973319
What this trial is testing

Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Shengjing Hospital 450
Post-approval studies (Phase 4)Not Yet RecruitingNCT04929548
What this trial is testing

Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP

Who this might be right for
Breast Cancer
Wuhan University 20
Testing effectiveness (Phase 2)WithdrawnNCT04571710
What this trial is testing

A Trial of SHR1258 in Patients With Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd.
Next Page